Titre : Systèmes de transport d'acides aminés neutres

Systèmes de transport d'acides aminés neutres : Questions médicales fréquentes

Termes MeSH sélectionnés :

Multicenter Studies as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Systèmes de transport d'acides aminés neutres : Questions médicales les plus fréquentes", "headline": "Systèmes de transport d'acides aminés neutres : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Systèmes de transport d'acides aminés neutres : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-27", "dateModified": "2025-04-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Systèmes de transport d'acides aminés neutres" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Systèmes de transport d'acides aminés", "url": "https://questionsmedicales.fr/mesh/D026905", "about": { "@type": "MedicalCondition", "name": "Systèmes de transport d'acides aminés", "code": { "@type": "MedicalCode", "code": "D026905", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.200" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Système A de transport d'acides aminés", "alternateName": "Amino Acid Transport System A", "url": "https://questionsmedicales.fr/mesh/D026924", "about": { "@type": "MedicalCondition", "name": "Système A de transport d'acides aminés", "code": { "@type": "MedicalCode", "code": "D026924", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.200.500.100" } } }, { "@type": "MedicalWebPage", "name": "Système ASC de transport d'acides aminés", "alternateName": "Amino Acid Transport System ASC", "url": "https://questionsmedicales.fr/mesh/D026962", "about": { "@type": "MedicalCondition", "name": "Système ASC de transport d'acides aminés", "code": { "@type": "MedicalCode", "code": "D026962", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.200.500.200" } } }, { "@type": "MedicalWebPage", "name": "Système L de transport d'acides aminés", "alternateName": "Amino Acid Transport System L", "url": "https://questionsmedicales.fr/mesh/D027062", "about": { "@type": "MedicalCondition", "name": "Système L de transport d'acides aminés", "code": { "@type": "MedicalCode", "code": "D027062", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.200.500.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Systèmes de transport d'acides aminés neutres", "alternateName": "Amino Acid Transport Systems, Neutral", "code": { "@type": "MedicalCode", "code": "D026921", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Stefan Bröer", "url": "https://questionsmedicales.fr/author/Stefan%20Br%C3%B6er", "affiliation": { "@type": "Organization", "name": "Research School of Biology, Australian National University, Canberra, ACT, Australia." } }, { "@type": "Person", "name": "Kiran Javed", "url": "https://questionsmedicales.fr/author/Kiran%20Javed", "affiliation": { "@type": "Organization", "name": "Research School of Biology, Australian National University, Canberra, ACT, Australia." } }, { "@type": "Person", "name": "Bowen Wu", "url": "https://questionsmedicales.fr/author/Bowen%20Wu", "affiliation": { "@type": "Organization", "name": "Institute of Rice Industry Technology Research, Key Laboratory of Functional Agriculture of Guizhou Provincial, Department of Education, Key Laboratory of Molecular Breeding for Grain and oil Crops in Guizhou Province, College of Agricultural Sciences, Guizhou University, Guiyang, 550025, China." } }, { "@type": "Person", "name": "Zhongming Fang", "url": "https://questionsmedicales.fr/author/Zhongming%20Fang", "affiliation": { "@type": "Organization", "name": "Institute of Rice Industry Technology Research, Key Laboratory of Functional Agriculture of Guizhou Provincial, Department of Education, Key Laboratory of Molecular Breeding for Grain and oil Crops in Guizhou Province, College of Agricultural Sciences, Guizhou University, Guiyang, 550025, China. zmfang@gzu.edu.cn." } }, { "@type": "Person", "name": "Cesare Indiveri", "url": "https://questionsmedicales.fr/author/Cesare%20Indiveri", "affiliation": { "@type": "Organization", "name": "Department of DiBEST (Biologia, Ecologia, Scienze Della Terra) Unit of Biochemistry and Molecular Biotechnology, University of Calabria, Via Bucci 4C, 87036, Arcavacata Di Rende, CS, Italy. cesare.indiveri@unical.it." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Antineutrophil Cytoplasm Antibody-Associated Vasculitides Valvular Impairment: Multicenter Retrospective Study and Systematic Review of the Literature.", "datePublished": "2022-07-15", "url": "https://questionsmedicales.fr/article/35840158", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3899/jrheum.211379" } }, { "@type": "ScholarlyArticle", "name": "Ophthalmic histiocytic lesions (diseases of the L group): A multicenter clinicopathological study of 18 cases and review of literature.", "datePublished": "2022-07-11", "url": "https://questionsmedicales.fr/article/35816372", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/11206721221113431" } }, { "@type": "ScholarlyArticle", "name": "Modified prolonged exposure therapy as Early Intervention after Rape (The EIR-study): study protocol for a multicenter randomized add-on superiority trial.", "datePublished": "2023-02-21", "url": "https://questionsmedicales.fr/article/36810120", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-023-07147-w" } }, { "@type": "ScholarlyArticle", "name": "Pathogen spectrum and immunotherapy in patients with anti-IFN-γ autoantibodies: A multicenter retrospective study and systematic review.", "datePublished": "2022-12-08", "url": "https://questionsmedicales.fr/article/36569827", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.1051673" } }, { "@type": "ScholarlyArticle", "name": "Clinical efficacy of mandibular complete dentures with a resilient liner: study protocol for a multicenter randomized controlled trial.", "datePublished": "2022-09-02", "url": "https://questionsmedicales.fr/article/36056410", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-022-06657-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Protéines de transport membranaire", "item": "https://questionsmedicales.fr/mesh/D026901" }, { "@type": "ListItem", "position": 6, "name": "Systèmes de transport d'acides aminés", "item": "https://questionsmedicales.fr/mesh/D026905" }, { "@type": "ListItem", "position": 7, "name": "Systèmes de transport d'acides aminés neutres", "item": "https://questionsmedicales.fr/mesh/D026921" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Systèmes de transport d'acides aminés neutres - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Systèmes de transport d'acides aminés neutres", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Systèmes de transport d'acides aminés neutres", "description": "Comment diagnostiquer un trouble de transport d'acides aminés ?\nQuels examens sont utilisés pour évaluer le transport d'acides aminés ?\nLes symptômes peuvent-ils indiquer un trouble de transport ?\nQuel rôle joue l'historique médical dans le diagnostic ?\nLes tests de dépistage néonatal incluent-ils ces troubles ?", "url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Multicenter+Studies+as+Topic&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Systèmes de transport d'acides aminés neutres", "description": "Quels sont les symptômes d'un trouble de transport d'acides aminés ?\nLes troubles digestifs sont-ils liés à ces systèmes ?\nPeut-on observer des anomalies neurologiques ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des signes cutanés associés ?", "url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Multicenter+Studies+as+Topic&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Systèmes de transport d'acides aminés neutres", "description": "Peut-on prévenir les troubles de transport d'acides aminés ?\nL'alimentation joue-t-elle un rôle préventif ?\nLes conseils génétiques sont-ils utiles ?\nLe suivi médical régulier est-il important ?\nLes vaccinations ont-elles un impact ?", "url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Multicenter+Studies+as+Topic&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Systèmes de transport d'acides aminés neutres", "description": "Quels traitements sont disponibles pour ces troubles ?\nLa thérapie génique est-elle une option ?\nLes médicaments peuvent-ils aider ?\nComment un régime alimentaire peut-il aider ?\nY a-t-il des traitements expérimentaux ?", "url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Multicenter+Studies+as+Topic&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Systèmes de transport d'acides aminés neutres", "description": "Quelles complications peuvent survenir ?\nLes troubles psychologiques sont-ils possibles ?\nY a-t-il des risques de maladies métaboliques ?\nLes complications peuvent-elles affecter la qualité de vie ?\nDes problèmes de croissance peuvent-ils survenir ?", "url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Multicenter+Studies+as+Topic&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Systèmes de transport d'acides aminés neutres", "description": "Quels sont les facteurs de risque génétiques ?\nL'alimentation peut-elle influencer le risque ?\nLes infections peuvent-elles aggraver la situation ?\nL'âge parental joue-t-il un rôle ?\nY a-t-il des facteurs environnementaux à considérer ?", "url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Multicenter+Studies+as+Topic&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un trouble de transport d'acides aminés ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses sanguines peuvent être effectués pour évaluer le transport." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer le transport d'acides aminés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de concentration d'acides aminés dans le sang et l'urine sont courants." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils indiquer un trouble de transport ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la fatigue ou des troubles de croissance peuvent alerter." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier des antécédents familiaux de troubles métaboliques." } }, { "@type": "Question", "name": "Les tests de dépistage néonatal incluent-ils ces troubles ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains programmes de dépistage néonatal incluent des tests pour ces troubles." } }, { "@type": "Question", "name": "Quels sont les symptômes d'un trouble de transport d'acides aminés ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, retard de croissance et troubles neurologiques." } }, { "@type": "Question", "name": "Les troubles digestifs sont-ils liés à ces systèmes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles digestifs peuvent survenir en raison d'une malabsorption des acides aminés." } }, { "@type": "Question", "name": "Peut-on observer des anomalies neurologiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies neurologiques peuvent se manifester en raison d'un manque d'acides aminés." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon l'âge et le type de trouble de transport." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Certaines carences peuvent entraîner des éruptions cutanées ou des problèmes dermatologiques." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles de transport d'acides aminés ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est limitée, mais un dépistage précoce peut aider à gérer les cas." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle préventif ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut aider à prévenir certaines carences en acides aminés." } }, { "@type": "Question", "name": "Les conseils génétiques sont-ils utiles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les conseils génétiques peuvent aider les familles à comprendre les risques héréditaires." } }, { "@type": "Question", "name": "Le suivi médical régulier est-il important ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi médical régulier peut aider à détecter les problèmes tôt." } }, { "@type": "Question", "name": "Les vaccinations ont-elles un impact ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations n'ont pas d'impact direct sur les troubles de transport d'acides aminés." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour ces troubles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des régimes alimentaires spécifiques et des suppléments d'acides aminés." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en cours d'étude pour certains troubles de transport d'acides aminés." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent améliorer l'absorption ou réduire les symptômes associés." } }, { "@type": "Question", "name": "Comment un régime alimentaire peut-il aider ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un régime adapté peut compenser les carences en acides aminés et améliorer la santé." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements expérimentaux sont en cours pour certains troubles rares." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des retards de développement et des troubles neurologiques." } }, { "@type": "Question", "name": "Les troubles psychologiques sont-ils possibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles psychologiques peuvent survenir en raison de carences nutritionnelles." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies métaboliques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies métaboliques peuvent se développer si les troubles ne sont pas traités." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients." } }, { "@type": "Question", "name": "Des problèmes de croissance peuvent-ils survenir ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes de croissance sont fréquents chez les enfants atteints de ces troubles." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque génétiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de troubles métaboliques augmentent le risque." } }, { "@type": "Question", "name": "L'alimentation peut-elle influencer le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation pauvre en acides aminés peut augmenter le risque de carences." } }, { "@type": "Question", "name": "Les infections peuvent-elles aggraver la situation ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent exacerber les symptômes des troubles de transport." } }, { "@type": "Question", "name": "L'âge parental joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge avancé des parents peut être un facteur de risque pour certaines anomalies." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux à considérer ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains facteurs environnementaux peuvent influencer le développement de ces troubles." } } ] } ] }

Sources (10000 au total)

Antineutrophil Cytoplasm Antibody-Associated Vasculitides Valvular Impairment: Multicenter Retrospective Study and Systematic Review of the Literature.

While myocardial impairment is a predictor of poor prognosis in antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV), little is known about valvular involvement. This study aims at d... We conducted a multicenter retrospective study in centers affiliated with the French Vasculitis Study Group. We included patients with granulomatosis with polyangiitis (GPA), microscopic polyangiitis ... The retrospective cohort included 9 patients (82%) with GPA, 1 (9%) with MPA, and 1 (9%) with unclassified AAV. Clinical presentation included acute valvular insufficiency (n = 7, 64%), cardiac failur... Endocarditis is a rare and potentially life-threatening manifestation of AAV. Acute valvular insufficiency may lead to urgent surgery. Implementing transthoracic echocardiography in standard assessmen...

Ophthalmic histiocytic lesions (diseases of the L group): A multicenter clinicopathological study of 18 cases and review of literature.

Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD) are rare histiocytic disorders in the L (Langerhans) group diseases. They range from self-limited benign diseases to lethal dissem... This retrospective study was conducted in 3 tertiary hospitals in Saudi Arabia and Brazil. Histopathological records were searched for all patients diagnosed with ocular and periocular histiocytic dis... Twenty-two eyes of 18 patients with biopsy-proven histiocytic disorders in the L group were included. Female-to-male ratio was 1.25:1. Average age at presentation was 14 years (range, 1-54). LCH was d... Histiocytic disorders are a rare group of diseases, including the L group. Relevant systemic associations require specific and selective therapy. A high clinical index and multidisciplinary collaborat...

Modified prolonged exposure therapy as Early Intervention after Rape (The EIR-study): study protocol for a multicenter randomized add-on superiority trial.

Sexual assault and rape are the traumatic life events with the highest probability for posttraumatic stress disorder (PTSD), which can have devastating consequences for those afflicted by the conditio... This is a multicenter randomized controlled add-on superiority trial that enrolls patients attending sexual assault centers within 72 h after rape or attempted rape. The objective is to assess whether... This study will guide further research and clinical initiatives for implementing strategies for preventing post-traumatic stress symptoms after rape and provide new knowledge about which women may ben... ClinicalTrials.gov NCT05489133. Registered on 3 August 2022....

Pathogen spectrum and immunotherapy in patients with anti-IFN-γ autoantibodies: A multicenter retrospective study and systematic review.

Anti-interferon-γ autoantibody (AIGA) positivity is an emerging immunodeficiency syndrome closely associated with intracellular infection in individuals without human immunodeficiency virus (HIV). How... This systematic literature review and multicenter retrospective study aimed to describe the pathogen spectrum and review treatment strategies among patients with AIGA positivity.... We included 810 HIV-negative patients with AIGA positivity infected with one or more intracellular pathogens. Excluding four teenagers, all the patients were adults. The most common pathogen was nontu... Intracellular pathogen was the most common infection in patients with AIGA positivity. The predominant infection phenotypes were NTM, varicella-zoster virus,...

Clinical efficacy of mandibular complete dentures with a resilient liner: study protocol for a multicenter randomized controlled trial.

During restoration of poorly fitting complete dentures (CDs) in edentulous patients, liners are used to reconstruct the concave surfaces of CDs with a new base material. These relining materials are c... The study is currently being conducted at eight centers, and a parallel-group randomized controlled trial (RCT) is underway. One hundred thirty-two edentulous patients with poorly fitting mandibular C... For dentists and prosthetic researchers in Japan, this RCT will provide information on the clinical efficacy of RL materials in comparison to RNL in CD wearers. The new evidence regarding the use of R... This clinical trial has been registered at the University Hospital Medical Information Network (UMIN) Center (UMIN000041950)....

Lifestyles, arterial aging, and its relationship with the intestinal and oral microbiota (MIVAS III study): a research protocol for a cross-sectional multicenter study.

The microbiota is increasingly recognized as a significant factor in the pathophysiology of many diseases, including cardiometabolic diseases, with lifestyles probably exerting the greatest influence ... MIVAS III is a multicenter cross-sectional study that will take place in the Iberian Peninsula. One thousand subjects aged between 45 and 74 years without cardiovascular disease will be selected. The ... Lifestyle acts as a modifier of microbiota composition. However, there are no conclusive results demonstrating the mediating effect of the microbiota in the relationship between lifestyles and cardiov... clinicaltrials.gov/ct2/show/NCT04924907, ClinicalTrials.gov, identifier: NCT04924907. Registered on 21 April 2021....

Cepharanthine and Oral Lichen Planus Efficacy (COLE) study: protocol for a multicentre randomised controlled study assessing the efficacy and safety of cepharanthine with topical corticosteroids in oral lichen planus.

Oral lichen planus (OLP) is a chronic, inflammatory oral condition leading to a range of symptoms from mild discomfort to severe pain, affecting patients' quality of life. Standard therapy involves th... This open-label, parallel-group, multi-centre, randomised controlled study will be conducted at three Japanese hospitals. It will compare safety and efficacy of integrated oral cepharanthine and corti... This protocol was approved by the Certified Review Board of Nara Medical University (CRB5200002). Participants will provide informed consent. Results will be disseminated in peer-reviewed journals and... Japan Registry of Clinical Trials (jRCTs051220130)....

Efficacy of methylene blue in refractory septic shock: study protocol for a multicenter, randomized, placebo-controlled trial.

Septic shock is now the leading cause of mortality in intensive care units (ICUs). Refractory septic shock requires high doses of vasopressors. Some previous studies have revealed that methylene blue ... This study is a multicenter, randomized, placebo-controlled trial planning to include 100 refractory septic shock patients. The protocol is to administer a bolus of 2 mg/kg methylene blue intravenousl... This protocol aims to evaluate the safety and efficacy of methylene blue as adjuvant therapy for refractory septic shock. The main outcome measure will be vasopressor requirements and hemodynamic para... This clinical trial has been registered at ChiCTR ( https://www.chictr.org.cn/ ) on March 16, 2023. ChiCTR registration number: ChiCTR2300069430....

Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.

In international guidelines, germline genetic testing is recommended for patients with metastatic prostate cancer. Before undergoing germline genetic testing, these patients should receive pre-test co... A multicenter prospective observational cohort study will be conducted in 15 hospitals, in different regions of the Netherlands. We developed an online training module on genetics in prostate cancer a... This study is intended to be one of the largest studies on mainstream genetic testing in prostate cancer. The results of this study can improve the mainstream genetic testing pathway in patients with ... The study is registered in the WHO's International Clinical Trials Registry Platform (ICTRP) under number NL9617....

Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric Cancer (POLA)-Study protocol for a single-arm prospective observational multicenter study.

In the era of neoadjuvant chemotherapy in advanced gastric cancer (GC), the role of staging laparoscopy (SL) will become more established. However, despite guidelines recommendations, SL for optimal p... This single-arm prospective observational multicenter study was approved by the Bioethical Committee of Medical University of Lublin (Ethic Code: KE-0254/331/2018). The protocol is registered at clini... POLA study is the first to investigate the clinical value of ICG-enhanced sentinel node biopsy during staging laparoscopy in advanced GC patients in a Western cohort. Identifying pN status before mult...